Precision BioSciences Receives FDA Fast Track Designation for PBGENE-DMD and Announces Duchenne Muscular Dystrophy Investor Event

Go back to Precision BioSciences Receives FDA Fast Track Designation for PBGENE-DMD and Announces Duchenne Muscular Dystrophy Investor Event
(NASDAQ: DTIL) Delayed: 7.29 --0 (-0%)
Previous Close $7.29    52 Week High
Open $7.29    52 Week Low
Day High $7.29    P/E N/A 
Day Low $7.29    EPS
Volume 85